Screenshot_20260814-194205.png
Explain what you see
Reading File
analyse_media
This is an Ultrasound Report of the Abdomen and Pelvis (from a female patient). Here is a structured breakdown of everything in it:
Normal Findings
| Organ | Finding |
|---|---|
| Liver | Normal size (13.3 cm), normal echotexture, no focal lesion, no bile duct dilatation within the liver |
| Spleen | Normal size (9.2 cm), normal echotexture, no focal lesion |
| Portal vein / IVC / Hepatic veins | All patent and normal |
| Kidneys | Right: 9.9 x 4.3 cm; Left: 9.8 x 4.8 cm - both normal in size, texture, and cortical differentiation; no stones |
| Bladder | Normally distended, normal wall thickness |
| Lymph nodes | No significantly enlarged nodes |
| Uterus | Anteverted, measures 5.5 x 6.2 x 3.5 cm, no myometrial lesion, endometrial thickness 6.8 mm (normal), cavity normal |
| Ovaries | Right: 2.0 x 1.8 cm; Left: 2.8 x 1.6 cm - both normal |
Abnormal / Noteworthy Findings
1. Bulky Pancreatic Head with Altered Echotexture
- The head of the pancreas measures 3.5 cm and appears larger and texturally abnormal on ultrasound.
- The main pancreatic duct (MPD) is not dilated - this is a reassuring sign, as dilation would raise more concern for obstruction or a mass.
- Possible causes include focal pancreatitis, an inflammatory mass, or rarely an early neoplastic process. Further imaging (CT or MRI of the pancreas) and correlation with serum amylase/lipase and CA 19-9 is typically recommended.
2. Cholelithiasis Without Cholecystitis (Gallstones)
- A gallbladder stone (calculus) measuring 3.8 mm is seen in the neck of the gallbladder.
- The gallbladder is partially distended but shows no signs of inflammation (no wall thickening, no pericholecystic fluid) - meaning this is simple cholelithiasis, not an acute cholecystitis.
- A stone in the gallbladder neck can intermittently block bile outflow and cause biliary colic (right upper quadrant pain, especially after fatty meals).
3. Mildly Prominent Common Bile Duct (CBD)
- The CBD measures 5.5 mm. The upper limit of normal is generally 6-8 mm (some use 6 mm as a cutoff).
- A 5.5 mm CBD is at the borderline - described here as "mild prominence." Given the gallstone in the gallbladder neck and the bulky pancreatic head, this mildly dilated CBD warrants attention, as it could indicate early external compression or partial obstruction.
4. Other Minor Findings
- Bilateral extra-renal pelvis: The renal pelvis extends slightly outside the kidney substance on both sides. This is a normal anatomical variant, not a disease.
- Minimal POD (Pouch of Douglas) free fluid: A tiny amount of free fluid in the pelvis. In women of reproductive age, this is commonly a normal physiological finding (especially around ovulation or menstruation). It becomes significant only if the amount is large or the clinical context suggests otherwise.
Impression (Doctor's Summary)
The radiologist highlighted three key findings:
- Bulky pancreatic head with altered echotexture - needs further evaluation
- Cholelithiasis without cholecystitis - gallstone present, no active infection/inflammation
- Mild prominent CBD - borderline bile duct widening, possibly related to the gallstone or pancreatic head abnormality
The report recommends clinical correlation - meaning the treating doctor should interpret these findings together with the patient's symptoms, blood tests, and clinical examination.
Note: This is a radiological report interpretation for informational purposes. A treating physician must review these findings in the context of the patient's full clinical picture before any diagnosis or management decision is made.
What should be next
Based on the ultrasound findings, here is what should typically happen next - the most important findings to act on are the bulky pancreatic head and the gallstone near the CBD.
Searching sources...
Finding Sources
Finding Sources
Searching PubMed
pancreatic head enlargement altered echotexture ultrasound evaluation
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here is a clear, prioritized action plan based on the three key findings in this report:
What Should Happen Next
Priority 1 - Bulky Pancreatic Head (Most Important)
This finding needs the most urgent follow-up. A bulky pancreatic head with altered echotexture on ultrasound has a broad differential that ranges from benign inflammation to something more serious, and ultrasound alone cannot distinguish between them.
Immediate blood tests:
- Serum Amylase and Lipase - if elevated >3x normal, this confirms pancreatitis. As noted in Bailey & Love's Surgery, lipase is more sensitive and specific than amylase.
- LFTs (Liver Function Tests) - bilirubin, ALT, AST, ALP to assess biliary involvement
- CA 19-9 and CEA - tumor markers to help screen for pancreatic malignancy (though not diagnostic alone)
- Blood glucose / HbA1c - pancreatic head pathology can impair insulin secretion
Imaging follow-up:
- MRCP (Magnetic Resonance Cholangiopancreatography) - the single most useful next step. It gives a detailed, non-invasive picture of the pancreatic duct, bile ducts, and the pancreatic tissue itself without radiation.
- CT Abdomen with contrast (triple phase) - if MRCP is not readily available, a contrast CT will better characterize the pancreatic head than ultrasound.
- EUS (Endoscopic Ultrasound) - if CT/MRI is inconclusive, EUS provides the highest resolution view of the pancreatic head and allows biopsy if needed. According to a 2022 review in Expert Review of Gastroenterology, EUS is the most sensitive tool for pancreatic lesion evaluation.
Specialist referral:
- Gastroenterology or Hepato-Pancreato-Biliary (HPB) surgeon consultation
Priority 2 - Gallstone + Mildly Prominent CBD
These two findings together are connected and need coordinated evaluation.
Blood tests:
- Serum bilirubin (total + direct) - elevated direct bilirubin would suggest the CBD is already partially obstructed
- ALP and GGT - sensitive markers of biliary obstruction
- LFTs - full liver panel
Imaging:
- MRCP (same as above - covers both the biliary tree and pancreas in one scan) - will show whether the 5.5 mm CBD is truly obstructed and whether there are any CBD stones (choledocholithiasis) that the ultrasound may have missed.
Management based on results:
- If CBD stones are confirmed on MRCP: ERCP (Endoscopic Retrograde Cholangiopancreatography) to clear the stone, followed by laparoscopic cholecystectomy to remove the gallbladder.
- If no CBD stones and CBD dilation is mild/isolated: elective laparoscopic cholecystectomy can be planned based on symptoms.
- As referenced in Maingot's Abdominal Operations, preoperative ERCP is selectively used based on clinical and imaging findings before cholecystectomy.
Priority 3 - Minimal POD Free Fluid
- In a woman of reproductive age this is almost certainly physiological (related to the menstrual cycle).
- No specific action needed unless the patient has symptoms (pelvic pain, fever) or the fluid is increasing on follow-up.
Summary Action Plan
| Step | What | Why |
|---|---|---|
| Now | Serum amylase, lipase, LFTs, bilirubin, CA 19-9, glucose | Identify pancreatitis, biliary obstruction, or malignancy markers |
| Soon (within days) | MRCP (preferred) or contrast CT abdomen | Best characterize pancreatic head + bile duct |
| Based on results | Gastroenterology / HPB consult | Guide further management |
| If CBD stones confirmed | ERCP + elective cholecystectomy | Clear bile duct obstruction, remove gallbladder |
| If pancreatic mass suspected | EUS + biopsy | Tissue diagnosis |
The single most important next step is getting an MRCP along with blood tests (amylase, lipase, LFTs, bilirubin, CA 19-9). These together will clarify whether the pancreatic finding is inflammatory or something that needs more urgent intervention. This should be coordinated by a gastroenterologist or general surgeon promptly.
Blood test
Reading File
Running Command
python3 -c " import pdfplumber with pdfplumber.open('/tmp/workspace/attachments/e22c5e6f-23a2-4976-afd7-024c5b79e947/LAB-Report (1).pdf') as pdf: for i, page in enumerate(pdf.pages): print(f'--- PAGE {i+1} ---') text = page.extract_text() print(text) print() "
Here is a full interpretation of all the blood and urine tests for Mrs. Tanya Tripty (29F), done at Manipal Hospital on 14/08/2026, ordered by Dr. Ashwini R Neelakanthi (OBG).
Complete Blood Count (CBC)
| Test | Result | Reference | Status |
|---|---|---|---|
| WBC | 6,520 /cumm | 4,000-11,000 | ✅ Normal |
| RBC | 3.83 million/cumm | 4.50-5.50 | 🔴 Low |
| Haemoglobin | 12.08 g/dL | 12.00-15.00 | ✅ Low-normal (borderline) |
| Haematocrit (PCV) | 36.30% | 36.00-46.00 | ✅ Low-normal (borderline) |
| MCV | 94.80 fL | 83-101 | ✅ Normal |
| MCH | 31.50 pg | 27-32 | ✅ Normal |
| MCHC | 33.30 g/dL | 31.5-34.5 | ✅ Normal |
| Platelets | 212,900 /cumm | 150,000-450,000 | ✅ Normal |
| Neutrophils | 63.96% | 40-70% | ✅ Normal |
| Absolute Eosinophils | 130 /cumm | 200-500 | 🟡 Mildly low |
Interpretation:
- RBC count is low while Hb is borderline (12.08 g/dL, just above the lower limit). MCV is normal (94.8 fL) - this is normocytic pattern, suggesting early/mild anaemia, possibly from nutritional deficiency (iron, B12/folate), chronic disease, or menstrual loss.
- No signs of infection (WBC normal, neutrophils normal).
- Mildly low absolute eosinophils - not clinically significant.
Liver Function Test (LFT)
| Test | Result | Reference | Status |
|---|---|---|---|
| Total Bilirubin | 0.69 mg/dL | 0.10-0.90 | ✅ Normal |
| Direct Bilirubin | 0.13 mg/dL | 0.00-0.20 | ✅ Normal |
| Indirect Bilirubin | 0.56 mg/dL | 0.20-1.60 | ✅ Normal |
| Total Protein | 7.1 g/dL | 6.0-8.3 | ✅ Normal |
| Albumin | 4.2 g/dL | 3.5-5.0 | ✅ Normal |
| SGOT/AST | 18 U/L | 5-40 | ✅ Normal |
| SGPT/ALT | 17 U/L | 5-40 | ✅ Normal |
| ALP | 68 U/L | 44-107 | ✅ Normal |
| GGT | 28 U/L | 12-38 | ✅ Normal |
Interpretation:
- The liver function is completely normal. Critically, bilirubin is normal (no jaundice, no biliary obstruction), and ALP and GGT are normal (no cholestasis). This is very reassuring - the mildly prominent CBD (5.5mm on US) is not causing any biochemical obstruction at this time. Liver enzymes (AST/ALT) are normal, ruling out active hepatitis or liver damage.
Kidney Profile
| Test | Result | Reference | Status |
|---|---|---|---|
| Creatinine | 0.60 mg/dL | 0.56-1.00 | ✅ Normal |
| Blood Urea Nitrogen | 6.40 mg/dL | 10-20 | 🟡 Low |
| Urea | 13.70 mg/dL | 14-43 | 🟡 Borderline low |
| Sodium | 137.13 mmol/L | 135-145 | ✅ Normal |
| Potassium | 4.33 mmol/L | 3.6-5.1 | ✅ Normal |
| Chloride | 105 mmol/L | 100-107 | ✅ Normal |
| Bicarbonate | 29 mmol/L | 21-31 | ✅ Normal |
| Random Glucose | 85 mg/dL | 70-140 | ✅ Normal |
Interpretation:
- Kidney function is normal. Creatinine is fine.
- BUN and Urea are slightly low - this is common in young women with low protein intake or good hydration and is not a concern.
- Random glucose is normal (85 mg/dL) - no diabetes. HbA1c is still pending, which will give a 3-month glucose average.
- Electrolytes are all normal.
TSH (Thyroid)
| Test | Result | Reference | Status |
|---|---|---|---|
| TSH | 1.470 µIU/mL | 0.400-4.200 | ✅ Normal |
Interpretation: Thyroid function is normal. No hypothyroidism or hyperthyroidism.
Serology
| Test | Result | Status |
|---|---|---|
| HBsAg (Hepatitis B) | 0.22 (Non-Reactive) | ✅ Negative |
| HCV Antibody (Hepatitis C) | 0.11 (Negative) | ✅ Negative |
| HIV 1 & 2 | Completed (result in report) | ✅ (presumed negative - no flag shown) |
All viral serology is negative - no hepatitis B, C, or HIV.
Urine Routine
| Test | Result | Status |
|---|---|---|
| Protein | Negative | ✅ Normal |
| Glucose | Negative | ✅ Normal |
| WBC/Pus cells | 2/HPF | ✅ Normal |
| Epithelial Cells | 13/HPF | 🟡 High (flagged) |
| Appearance | Slightly Cloudy | 🟡 Minor flag |
Interpretation: No infection (pus cells normal, nitrite negative, leucocyte esterase negative). The slightly cloudy appearance and high epithelial cells (13/HPF, normal is 0-4) are most likely due to vaginal contamination during collection - a very common finding in women and not clinically significant unless symptoms of UTI are present.
Overall Summary in Context of the Ultrasound
| Finding (from US) | Blood Test Correlation | Conclusion |
|---|---|---|
| Bulky pancreatic head | Amylase/Lipase not ordered yet | ⚠️ Still needs to be done |
| Gallstone + mildly prominent CBD | Bilirubin, ALP, GGT all normal | ✅ No active obstruction currently |
| Liver | LFTs completely normal | ✅ Good |
| Kidneys | Creatinine normal | ✅ Good |
| Minimal POD fluid | Not relevant to bloods | - |
What is Still Needed
- Serum Amylase and Lipase - critically, these were NOT ordered and are the most important tests to evaluate the bulky pancreatic head. This must be added.
- CA 19-9 - tumor marker for pancreatic/biliary pathology - not yet ordered.
- HbA1c - still pending (in-progress). Will confirm long-term glucose control.
- MRCP - imaging remains the most important next step (see previous plan). Normal LFTs and bilirubin do not rule out early pancreatic pathology.
The reassuring news is that liver function, bilirubin, and bile duct enzymes are all completely normal, meaning the gallstone and CBD widening are not currently causing obstruction. The pancreatic finding remains the main outstanding concern requiring further evaluation.
This interpretation is for informational purposes only and should be reviewed by the treating physician, Dr. Ashwini R Neelakanthi.
This is a shared conversation. Sign in to Orris to start your own chat.